Torrey Growth & Income Advisors

Position in CADL — Candel Therapeutics, Inc.

CIK 2087822 DEL MAR, CA

Position in CADL

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$684,496

+$355,471 QoQ

Shares Held

66,456

-1.0% QoQ

Ownership

0.087%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#43

of 138 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Torrey Growth & Income Advisors holds $6,964,754 across 5 Biotechnology names. CADL ranks #5 (9.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,710	$2,339,598
2	VCEL	Vericel Corp	38,308	$1,704,322
3	NTLA	Intellia Therapeutics, Inc.	70,669	$1,195,719
4	IBRX	ImmunityBio, Inc.	118,860	$1,040,619
5	CADL	Candel Therapeutics, Inc. This page	66,456	$684,496

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$684,496	66,456	-1.0%	Shares	Sole	2026-07-27
2026-03-31	$329,025	67,148	+0.6%	Shares	Sole	2026-04-21
2025-12-31	$377,137	66,750	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.